SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

BRIEF-Achilles Therapeutics Reports Q1 Loss Per Share Of $8.38

05/11/2021 08:59
BRIEF-Achilles Therapeutics Reports Q1 Loss Per Share Of $8.38

- Achilles Therapeutics PLC 698y.F:

  • ACHILLES THERAPEUTICS REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

  • Q1 LOSS PER SHARE $8.38

  • EXPECTS EXISTING CASH AND CASH EQUIVALENTS PLUS IPO PROCEEDS ARE SUFFICIENT TO FUND PLANNED OPERATIONS INTO H2 2023

Source text for Eikon: ID:nGNX9dJZtj

Further company coverage: 698y.F


(([email protected];))